@article{eafd93ef02eb4b4abc9b99584b317b9c,
title = "Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer",
abstract = "There is an unmet need for predictive markers for the antiangiogenic agent bevacizumab in metastatic colorectal cancer (mCRC). We aimed to assess whether the location of the primary tumor is associated with bevacizumab effectiveness when combined with capecitabine and oxaliplatin (CAPEOX) in the first-line treatment of patients with mCRC.",
keywords = "Bevacizumab, Biomarker, Chemotherapy, Metastatic colorectal cancer, Primary tumor",
author = "Boisen, {M K} and Johansen, {J S} and Christian Dehlendorff and Larsen, {J S} and K Osterlind and J Hansen and Nielsen, {S E} and P Pfeiffer and Tarpgaard, {Line Schmidt} and Holl{\"a}nder, {N H} and N Keldsen and Hansen, {T F} and Jensen, {B B} and Jensen, {B V}",
year = "2013",
month = oct,
doi = "10.1093/annonc/mdt253",
language = "English",
volume = "24",
pages = "2554--2559",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Elsevier",
number = "10",
}